Tennis

Swiatek, Sinner discuss their doping cases ahead of the Australian Open

Jannik Sinner and Iga Swiatek were both able to go for months last season without anyone knowing what was happening behind the scenes and that they'd failed doping tests.

Sinner gets April date at sports court for appeal hearing in doping case

Composite photo of Jannik Sinner and Iga Swiatek competing in separate singles matches at the U.S. Open tennis tournament in New York on Aug. 29, 2024.
Tennis stars Jannik Sinner, left, and Iga Swiatek, right, both failed doping tests in 2024. (CBC Sports composite/Al Bello/Getty Images)

Iga Swiatek, a self-described "control freak," is taking new precautions — including holding on to extra samples of medicine she takes, in case they need to be tested at some point — after a doping case she described Friday as "probably, like, the worst time in my life."

Jannik Sinner, another player who spent time at No. 1 and tested positive in 2024, will go to sport's highest court in April for the World Anti-Doping Agency's appeal that seeks to ban him from the sport for at least one year.

The Court of Arbitration for Sport said Friday it scheduled a closed-doors hearing on April 16-17 at its headquarters in Lausanne, Switzerland.

WADA is challenging a decision last year by the International Tennis Integrity Agency (ITIA) not to suspend Sinner for what it judged was accidental contamination by a banned anabolic steroid last March.

As confident as he repeatedly has said he is about the eventual outcome, the 23-year-old Italian acknowledged that it's on his mind as the year's first Grand Slam tournament is set to begin Sunday.

"Yeah, you think about this, of course," Sinner said. "I would lie if I would tell you I forget."

He and Swiatek, a five-time major champion, both were able to go for months last season without anyone knowing what was happening behind the scenes and that they'd failed tests.

Sinner tested positive twice for trace amounts of an anabolic steroid at a tournament in March; those results — and the fact that he was cleared by the International Tennis Integrity Agency (ITIA) — did not come out until August, shortly before the start of the U.S. Open, which he would go on to win. He was cleared because the ITIA accepted his explanation: A trainer exposed Sinner to a banned substance by giving him a massage shortly after using a cream on his own injured finger.

Swiatek failed an out-of-competition drug test in August, but her one-month suspension wasn't known until late November, after she sat out three events without revealing why. By the time her case was announced by the ITIA — which accepted that her sample was tainted because of a contaminated sleep aid — all that was left for her to serve was a week, which landed in the offseason.

On Friday, Swiatek described the initial period she was sidelined, which she talked up at the time to personal reasons, as "pretty chaotic" and said, "For sure, it wasn't easy; it was probably, like, the worst time in my life."

"It got pretty awkward. Like we chose for the first tournament to say 'personal reasons' because we honestly thought the suspension is going to be lifted soon. From the beginning it was obvious that something was contaminated because the level of this substance in my urine was so low that it had to be contamination," Swiatek said.

"We started, yeah with 'personal issues,"' she added, "because I needed also time to figure everything out."

Swiatek said she was worried about what other players' reactions would be at the start of this season.

"Besides the fact I couldn't play, this was the worst thing for me: What people would say. Because I always worked hard to be a good example, to show my integrity, show good behaviour," she said. "Having no control over this case really freaked me out a bit. But in the locker room, I mean, the girls are great."

Add some “good” to your morning and evening.

Get up to speed on what's happening in sports. Delivered weekdays.

...

The next issue of The Buzzer will soon be in your inbox.

Discover all CBC newsletters in the Subscription Centre.opens new window

This site is protected by reCAPTCHA and the Google Privacy Policy and Google Terms of Service apply.